OASL expression in CD19+ B cells showed no significant difference between active SLE patients and healthy participants, but OAS2 and OAS3 expression in CD19+ B were notably up-regulated in active SLE patients (P<0.05). The gene discussed is CD19; the disease is systemic lupus erythematosus.